Brean Capital Downgrades Medivation (MDVN) to Hold
- Dow, S&P 500 surge to highs; transports set record
- Unusual 11 Mid-Day Movers 12/7: (ANTH) (EMKR) (PLAY) Higher; (SIGM) (OHAI) (FTK) Lower
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Western Digital (WDC) Raises Q2 Outlook
- Biotech, Pharma Stocks Weaker Amid Trump Comments on Lower Drug Prices
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Brean Capital downgraded Medivation (NASDAQ: MDVN) from Buy to Hold.
Shares of Medivation closed at $67.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Western Digital (WDC) PT Raised to $100 at Brean Capital on Way to $120
- RBC Capital Downgrades Concordia Healthcare (CXRX) to Underperform, $1 PT
- B. Riley Downgrades Jabil Circuit (JBL) to Neutral
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesBrean Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!